CoChat

Pharmacokinetic–pharmacodynamic modelling of QT interval prolongation following citalopram overdoses

Open access
Friberg, Lena E., Isbister, Geoffrey K., Duffull, Stephen B. · 2006 · British Journal of Clinical Pharmacology
Cited by 92

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Aims: To develop a pharmacokinetic–pharmacodynamic model describing the time‐course of QT interval prolongation after citalopram overdose and to evaluate the effect of charcoal on the relative risk of developing abnormal QT and heart‐rate combinations. Methods: Plasma concentrations and electrocardiograph (ECG) data from 52 patients after 62 citalopram overdose events were analysed in WinBUGS using a Bayesian approach. The reported doses ranged from 20 to 1700 mg and on 17 of the events a single dose of activated charcoal was administered. The developed pharmacokinetic–pharmacodynamic model was used for predicting the probability of having abnormal combinations of QT‐RR, which was assumed to be related to an increased risk for torsade de pointes (TdP). Results: The absolute QT interval was related to the observed heart rate with an estimated individual heart‐rate correction factor [α = 0.36, between‐subject coefficient of variation (CV) = 29%]. The heart‐rate corrected QT interval was linearly dependent on the predicted citalopram concentration (slope = 40 ms l mg−1, between‐subject CV = 70%) in a hypothetical effect‐compartment (half‐life of effect‐delay = 1.4 h). The heart‐rate corrected QT was predicted to be higher in women than in men and to increase with age. Administration of activated charcoal resulted in a pronounced reduction of the QT prolongation and was shown to reduce the risk of having abnormal combinations of QT‐RR by approximately 60% for citalopram doses above 600 mg. Conclusion: Citalopram caused a delayed lengthening of the QT interval. Administration of activated charcoal was shown to reduce the risk that the QT interval exceeds a previously defined threshold and therefore is expected to reduce the risk of TdP.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2125.2005.02546.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 92

Metadata

Authors
Friberg, L. E., Isbister, G. K., & Duffull, S. B.
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
2005-12
Volume
61
Issue
2
Pages
177-190
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W2036823079
Cited by
92
References
2
FWCI
5.92
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacokinetic–pharmacodynamic modelling of QT interval prolongation following citalopram overdoses. https://app.cochat.ai/papers/10.1111/j.1365-2125.2005.02546.x
The paper
Friberg, L. E., Isbister, G. K., & Duffull, S. B. (2006). Pharmacokinetic–pharmacodynamic modelling of QT interval prolongation following citalopram overdoses. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2005.02546.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.